Development of Ultraviolet Spectrophotometric Method for Analysis of Lornoxicam in Solid Dosage Forms
Purpose: An ultraviolet spectrophotometric system was developed and validated for the quantitative determination of lornoxicam in solid dosage forms.
Methods: Lornoxicam was dissolved in 0.01M NaOH and analysed using ultraviolet (UV) spectrophotometry. Various analytical parameters such as linearity, precision, accuracy, limit of detection (LOD) and limit of quantification (LOQ) were determined according to International Conference on Harmonization (ICH) guidelines.
Results: Absorbance maximum in 0.01M NaOH was 377 nm. Beer’s law was obeyed over the concentration range of 2 - 20 mg/ml with a correlation coefficient (r2) value of 0.999. Percent range of error was 0.344 and 0.261 at 0.05 and. 0.01 confidence limits, respectively. Intra- and inter-day precision (% RSD) at different concentration levels were < 2 %, indicating that the proposed derivative spectrophotometric method is highly reproducible during one run and between different runs; LOD and LOQ were 0.105 and 0.318 mg/ml, respectively signifying that it can be adopted for routine quality testing. Mean recovery was 100.82 % for tablets. Low values of % RSD indicate the reliability of the proposed method
Conclusion: The proposed method is highly sensitive, precise, accurate, cost-effective, reliable and rapid for the estimation of lornoxicam in solid dosage forms.
Keywords: Lornoxicam, UV Spectrophotometry, Quantitative determination, Solid dosage forms.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.